Jacob T. Painter
Professor
Also affiliated: United States Department of Veterans Affairs (2023–2024); University of Kentucky (2010–2014); Durham University (2012); University of Arkansas Medical Center (2022–2026); Health Services Research & Development (2024); Experimental Pathology Laboratories (2008–2012); Triangle (2008–2012); Central Arkansas Veterans Healthcare System (2013–2026); Integrated Laboratory Systems, Inc. (2009–2012); Department of Biological Sciences (2017); Medicines Evaluation Unit (2022); John L. McClellan Memorial Veterans Hospital (2021)
Faculty Researcher
Pharmacy Practice, College of Pharmacy
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Jacob T. Painter, Professor in Pharmacy Practice at the University of Arkansas for Medical Sciences, focuses his research on pharmacological effects and patient outcomes, particularly concerning pain management and opioid use. His work investigates risk factors and clinical outcomes associated with various medical conditions, including blood culture contamination and the use of gabapentinoids and opioids in older breast cancer survivors with neuropathic pain.
Painter's research also extends to care models aimed at improving pain management and reducing opioid reliance among patients on long-term opioid therapy. He has examined the role of buprenorphine in managing pain and opioid use in this patient population. His scholarship includes studies on depression and diabetes distress in patients with diabetes, as well as the real-world survival of first-line immune checkpoint inhibitor treatment versus chemotherapy in older patients with non–small-cell lung cancer and brain metastases. His publication record demonstrates a commitment to analyzing real-world data to inform clinical practice.
With an h-index of 23 and over 1,600 citations across 122 publications, Painter is recognized as a highly cited researcher. He actively collaborates with colleagues at the University of Arkansas for Medical Sciences, including Bradley C. Martin and Chenghui Li, with whom he has co-authored multiple publications. He also maintains an active lab website.
Metrics
- h-index: 23
- Publications: 123
- Citations: 1,683
Selected Publications
-
State X-waiver Statutes and Buprenorphine Prescriber Rates Following Federal X-waiver Elimination, 2021–2023 (2026)
-
CO145 EFFICACY AND EFFECTIVENESS OF IMMUNE CHECKPOINT INHIBITORS IN TRIPLE-NEGATIVE BREAST CANCER: A SYSTEMATIC LITERATURE REVIEW (2026)
-
The Veterans Affairs’ Whole Health Approach for Chronic Pain Management (2026)
-
A Gift of the Magi Paradox? Patient and Clinician Perspectives on Deprescribing (2026)
-
Effect of Long-Term Opioid Therapy on Sexual Dysfunction in Pain Patients (2025)
-
Estimating the value of an early childhood education nutrition program (2025)
-
Pragmatic Comparative Effectiveness of Primary Care Treatments for Posttraumatic Stress Disorder (2025)
-
Measurement of Practice-Level Antibiotic Utilization in a Medicaid Patient-Centered Medical Home Program (2025)
-
Survival Outcomes of Immune Checkpoint Inhibitors in Conjunction with Cranial Radiation for Older Adults with Non-Small Cell Lung Cancer and Synchronous Brain Metastasis (2025)
-
Buprenorphine, Pain, and Opioid Use in Patients Taking High-Dose Long-Term Opioids (2025)
-
Factors Contributing to Opioid Overprescribing at Surgical Discharge (2025)
-
Care Models to Improve Pain and Reduce Opioids Among Patients Prescribed Long-Term Opioid Therapy (2024)
-
Assessment of Metformin Intolerance: A Retrospective Chart Review (2024)
-
Implementation of collaborative care for depression in VA HIV clinics: Translating Initiatives for Depression into Effective Solutions (HITIDES): protocol for a cluster-randomized type 3 hybrid effectiveness-implementation trial (2024)
-
Outpatient Patient Controlled Analgesia (PCA) for the Palliative Care Patient (2024)
Federal Grants 1
Grants & Funding
As listed on this researcher's institutional profile. Federal awards with verified records are shown above.
- HEAL Initiative: Integrative Management of chronic Pain and OUD for Whole Recovery (IMPOWR): Research Centers NIH/Nat. Inst. on Drug Abuse via Yale University Principal Investigator
- Implementation of a Pragmatic Trial of Whole Health Team vs. Primary Care Group Education to Promote Non-Pharmacological Strategies to Improve Pain, Functioning, and Quality of Life in Veterans NIH/National Institutes of Health via Northern California Institute for Research and Education Principal Investigator
- Home Food Delivery for Diabetes Management in Patients of Rural Clinics NIH/Nat. Inst. of Nursing Research Principal Investigator
- Center for Childhood Obesity Prevention NIH Principal Investigator
- Addressing COVID 19 Vaccine Hesitancy in Rural Community Pharmacies Reducing Disparities Through an Implementation Science Approach NIH Principal Investigator
- Data to Clinical Action: Using Predictive Analytics to Improve Care of Veterans with Opioid Use Disorder VA HSR&D Co-Investigator
- Testing an Adaptive Implementation Strategy to Optimize Delivery of Obesity Prevention Practices in Early Care and Education Settings NIH Co-Investigator
Collaboration Network
Top Collaborators
- The use of gabapentinoids and opioids and risk of developing opioid-induced respiratory depression among older breast cancer survivors with neuropathic pain
- Factors Associated With Guideline-Concordant Pharmacological Treatment for Neuropathic Pain Among Breast Cancer Survivors
- Healthcare costs and utilization associated with pain among breast cancer survivors: a propensity score matched cohort study using SEER-Medicare data
- Opioid therapy trajectories of patients with chronic non-cancer pain over 1 year of follow-up after initiation of short-acting opioid formulations
- The Effect of Concurrent Use of Opioids and Gabapentin on Fall Risk in Older Adults
Showing 5 of 11 shared publications
- Real-World Survival of First-Line Immune Checkpoint Inhibitor Treatment Versus Chemotherapy in Older Patients With Non–Small-Cell Lung Cancer and Synchronous Brain Metastases
- The use of gabapentinoids and opioids and risk of developing opioid-induced respiratory depression among older breast cancer survivors with neuropathic pain
- Healthcare costs and utilization associated with pain among breast cancer survivors: a propensity score matched cohort study using SEER-Medicare data
- Food Insecurity and Health Outcomes of Children With Intellectual and Developmental Disabilities in the United States
- Opioid therapy trajectories of patients with chronic non-cancer pain over 1 year of follow-up after initiation of short-acting opioid formulations
Showing 5 of 9 shared publications
- Real-World Survival of First-Line Immune Checkpoint Inhibitor Treatment Versus Chemotherapy in Older Patients With Non–Small-Cell Lung Cancer and Synchronous Brain Metastases
- The use of gabapentinoids and opioids and risk of developing opioid-induced respiratory depression among older breast cancer survivors with neuropathic pain
- Factors Associated With Guideline-Concordant Pharmacological Treatment for Neuropathic Pain Among Breast Cancer Survivors
- Healthcare costs and utilization associated with pain among breast cancer survivors: a propensity score matched cohort study using SEER-Medicare data
- Opioid therapy trajectories of patients with chronic non-cancer pain over 1 year of follow-up after initiation of short-acting opioid formulations
Showing 5 of 9 shared publications
- Risk factors and clinical outcomes associated with blood culture contamination
- Depression and diabetes distress in patients with diabetes
- The use of gabapentinoids and opioids and risk of developing opioid-induced respiratory depression among older breast cancer survivors with neuropathic pain
- Factors Associated With Guideline-Concordant Pharmacological Treatment for Neuropathic Pain Among Breast Cancer Survivors
- Healthcare costs and utilization associated with pain among breast cancer survivors: a propensity score matched cohort study using SEER-Medicare data
Showing 5 of 6 shared publications
- Real-World Survival of First-Line Immune Checkpoint Inhibitor Treatment Versus Chemotherapy in Older Patients With Non–Small-Cell Lung Cancer and Synchronous Brain Metastases
- Factors associated with an increased risk of vitamin <scp>B<sub>12</sub></scp> deficiency in patients with type 2 diabetes mellitus on metformin
- Immune checkpoint inhibitors as subsequent treatment in older adults with non-small cell lung cancer and synchronous brain metastases
- Assessment of Metformin Intolerance: A Retrospective Chart Review
- Survival Outcomes of Immune Checkpoint Inhibitors in Conjunction with Cranial Radiation for Older Adults with Non-Small Cell Lung Cancer and Synchronous Brain Metastasis
Showing 5 of 6 shared publications
- The use of gabapentinoids and opioids and risk of developing opioid-induced respiratory depression among older breast cancer survivors with neuropathic pain
- Factors Associated With Guideline-Concordant Pharmacological Treatment for Neuropathic Pain Among Breast Cancer Survivors
- Healthcare costs and utilization associated with pain among breast cancer survivors: a propensity score matched cohort study using SEER-Medicare data
- Outpatient Patient Controlled Analgesia (PCA) for the Palliative Care Patient
- Economic analyses of behavioral health intervention implementation: Perspective on stakeholder engagement
- Engaging stakeholders to retrospectively discern implementation strategies to support program evaluation: Proposed method and case study
- OP8 Justice-Informed Analysis: A Unified Framework for Increasing Inclusivity and Methodological Rigor in Health Inequities Research
- Implementation of collaborative care for depression in VA HIV clinics: Translating Initiatives for Depression into Effective Solutions (HITIDES): protocol for a cluster-randomized type 3 hybrid effectiveness-implementation trial
- “Advancing” Advance Care Planning to Veterans in the Veterans Health Administration
- Engaging stakeholders to retrospectively discern implementation strategies to support program evaluation: Proposed method and case study
- Adopting the RE-AIM analytic framework for rural program evaluation: experiences from the Advance Care Planning via Group Visits (ACP-GV) national evaluation
- “Advancing” Advance Care Planning to Veterans in the Veterans Health Administration
- Addressing COVID-19 vaccine hesitancy in rural community pharmacies: a protocol for a stepped wedge randomized clinical trial
- Adopting the RE-AIM analytic framework for rural program evaluation: experiences from the Advance Care Planning via Group Visits (ACP-GV) national evaluation
- “Advancing” Advance Care Planning to Veterans in the Veterans Health Administration
- Engaging stakeholders to retrospectively discern implementation strategies to support program evaluation: Proposed method and case study
- Adopting the RE-AIM analytic framework for rural program evaluation: experiences from the Advance Care Planning via Group Visits (ACP-GV) national evaluation
- “Advancing” Advance Care Planning to Veterans in the Veterans Health Administration
- Engaging stakeholders to retrospectively discern implementation strategies to support program evaluation: Proposed method and case study
- Adopting the RE-AIM analytic framework for rural program evaluation: experiences from the Advance Care Planning via Group Visits (ACP-GV) national evaluation
- “Advancing” Advance Care Planning to Veterans in the Veterans Health Administration
- Engaging stakeholders to retrospectively discern implementation strategies to support program evaluation: Proposed method and case study
- Adopting the RE-AIM analytic framework for rural program evaluation: experiences from the Advance Care Planning via Group Visits (ACP-GV) national evaluation
- Depression and diabetes distress in patients with diabetes
- Factors associated with an increased risk of vitamin <scp>B<sub>12</sub></scp> deficiency in patients with type 2 diabetes mellitus on metformin
- Assessment of Metformin Intolerance: A Retrospective Chart Review
- Real-World Survival of First-Line Immune Checkpoint Inhibitor Treatment Versus Chemotherapy in Older Patients With Non–Small-Cell Lung Cancer and Synchronous Brain Metastases
- Immune checkpoint inhibitors as subsequent treatment in older adults with non-small cell lung cancer and synchronous brain metastases
- Survival Outcomes of Immune Checkpoint Inhibitors in Conjunction with Cranial Radiation for Older Adults with Non-Small Cell Lung Cancer and Synchronous Brain Metastasis
- Real-World Survival of First-Line Immune Checkpoint Inhibitor Treatment Versus Chemotherapy in Older Patients With Non–Small-Cell Lung Cancer and Synchronous Brain Metastases
- Immune checkpoint inhibitors as subsequent treatment in older adults with non-small cell lung cancer and synchronous brain metastases
- Survival Outcomes of Immune Checkpoint Inhibitors in Conjunction with Cranial Radiation for Older Adults with Non-Small Cell Lung Cancer and Synchronous Brain Metastasis
Similar Researchers
Based on overlapping research topics